Trial Details

Recruiting
Basic Information
Clinical ID c2979
Identifier NCT02603185
Trial Title A First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Hemay007
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Inflammatory Bowel Disease;Inflammatory Bowel Disease;Inflammatory Bowel Disease;Inflammatory Bowel Disease
Interventions Drug: Hemay007;Drug: placebo;Drug: Hemay007;Drug: placebo;Drug: Hemay007;Drug: placebo;Drug: Hemay007;Drug: placebo
Participant Information
Sponsor Hemay Pharmaceutical PTY. LTD.
City -
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type Interventional
Phase PHASE1
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -